Assessment of Comparative Immunogenicity in Biosimilar Development: Immunogenicity and Pharmacokinetics Following a Single Dose of M923, a Proposed Biosimilar for Reference Adalimumab (HUMIRA (R)), Compared with US- and EU-Sourced Reference Adalimumab in Healthy Subjects

Conference Paper

Full Text

Link to Item

Duke Authors

Goel, Niti

Cited Authors

Hillson, J; Mant, T; Ganguly, T; Avery, W; Rosano, M; Huntenburg, C; Palmer, D; Darne, S; Pavlova, B; Doralt, J; Reeve, R; Goel, N; Weilert, D; Rhyne, P; Caminis, J; Roach, J

Published Date

October 1, 2016

Published In

Arthritis & Rheumatology

Volume / Issue

68 /

Published By

WILEY

Pages

2

Electronic International Standard Serial Number (EISSN)

2326-5205

International Standard Serial Number (ISSN)

2326-5191